Home/Filings/4/0001127602-25-006718
4//SEC Filing

Hopkinson Craig C. 4

Accession 0001127602-25-006718

CIK 0001520262other

Filed

Feb 24, 7:00 PM ET

Accepted

Feb 25, 6:35 PM ET

Size

13.3 KB

Accession

0001127602-25-006718

Insider Transaction Report

Form 4
Period: 2025-02-22
Hopkinson Craig C.
EVP R&D, Chief Medical Officer
Transactions
  • Exercise/Conversion

    Ordinary Shares

    2025-02-23+7,68977,337 total
  • Exercise/Conversion

    Restricted Stock Unit Award

    2025-02-237,68915,379 total
    Ordinary Shares (7,689 underlying)
  • Tax Payment

    Ordinary Shares

    2025-02-22$35.32/sh5,452$192,56569,648 total
  • Tax Payment

    Ordinary Shares

    2025-02-23$35.32/sh3,414$120,58273,923 total
  • Exercise/Conversion

    Restricted Stock Unit Award

    2025-02-2212,2790 total
    Ordinary Shares (12,279 underlying)
  • Exercise/Conversion

    Ordinary Shares

    2025-02-22+12,27975,100 total
Footnotes (3)
  • [F1]Each restricted stock unit represents a contingent right to receive one ordinary share.
  • [F2]This award is fully vested in accordance with its terms.
  • [F3]Shares subject to the restricted stock unit award vest in four equal annual installments, commencing on 2/23/2024.

Issuer

Alkermes plc.

CIK 0001520262

Entity typeother

Related Parties

1
  • filerCIK 0001730048

Filing Metadata

Form type
4
Filed
Feb 24, 7:00 PM ET
Accepted
Feb 25, 6:35 PM ET
Size
13.3 KB